Axoltis Pharma
Annette Janus, MD, currently serves as Chief Medical Officer at Axoltis Pharma, focusing on clinical drug development and medical leadership for CNS regeneration. Since January 2017, Annette has been a freelance Research Physician Consultant, providing expertise in pharmaceutical research, medical content, and graduate medical education. Previously, Annette held senior medical director positions at Worldwide Clinical Trials and ICON plc, contributing to clinical research and business development. From 2012 to 2017, Annette worked as Medical Director for Neurology at PRA Health Sciences, leading neuromuscular clinical trials. Earlier experience includes a role as Staff Neurologist and Neuromuscular Specialist at Louis Stokes Cleveland Veterans Affairs Medical Center. Annette's academic background includes advanced medical education from institutions such as the University of Oxford and Case Western Reserve University School of Medicine.
This person is not in any teams
This person is not in any offices
Axoltis Pharma
Axoltis pharma is a biopharmaceutical company dedicated to develop a first-in-class disease-modifying drug to treat patients with neurodegenerative or traumatic neurological disorders with high unmet medical needs. Our innovative approach: combining Preventative, Neuroprotective, Regenerative & Remodeling properties in a single drug, as the key to cure complex neurological disorders. Our products are first-in-class multifunctional peptides with high potential in many CNS disorders.